MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 10 - per page
Order by
Antroquinonol® is a non-toxic, highly effective cancer treatment agent, developed using natural organic chemistry. More
Breast Cancer, Lung cancer, Pancreatic caner(cytotoxic chemotheraphy) More
Third generation long-acting, site-specific PEGylated interferon-alpha, having one predominate positional isomer, offering a longer half-life and so requiring a less frequent dosage regime. The new design also gives improved production yields. More
Production process of C3 synthons by biotransformation. More
This invention describes improved methods for the large scale manufacture of stable disulfide-conjugated antibody therapeutics. More
Sensitive detection and characterization of macromolecular interactions in homogenous or heterogeneous solutions of biological and/or synthetic macromolecules More
A Spanish research group has patented a new method to prepare quaternary amino acid derivatives, containing azepane, oxoazepane or thioazepane skeletons, which have shown ability to induce peptide secondary structures when incorporated into small peptides More
Discovery that lasonolide A may be used as a new reagent for inducing premature chromosome condensation in non-dividing cells; and a novel anti-proliferative and anti-metastatic agent for cancer treatment More
This new multi-well plate/plug design reduces magnetic field distortions and should dramatically improve spectral resolution and sensitivity for NMR and MRI-based high-throughput screening. More
A comprehensive database of over 12,000 constituents from over 300 Chinese herbs incorporating all available chemical, botanical, and biological activity data More
Displaying 1..10 of 10 - per page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us